Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on January 11, 2008.
Experimental Physiology (2008)
DOI: 10.1113/expphysiol.2007.041806
© The Physiological Society 2008

A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
93/5/658    most recent
expphysiol.2007.041806v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brosnihan, K B.
Right arrow Articles by Gallagher, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brosnihan, K B.
Right arrow Articles by Gallagher, P.

Received December 17, 2007
Revised January 3, 2008
Accepted after revision January 3, 2008


Genomic Physiology [220]

Tissue Specific Regulation of ACE/ACE2 and AT1/AT2 Receptor Gene Expression By Estrogen in ApoE/ERá Knock-Out Mice

K Bridget Brosnihan 1*, Jeffrey B Hodgin 2, Oliver Smithies 2, Nobuyo Maeda 2, Patricia Gallagher 3

1 Wake Forest University
2 University of North Carolina at Chapel Hill
3 Wake Forest University Health Sciences

* To whom correspondence should be addressed. E-mail: bbrosnih{at}wfubmc.edu.


   Abstract
ACE and ACE2 and the AT1 and AT2 receptors are pivotal points of regulation in the renin-angiotensin system. ACE and ACE2 are key enzymes in the formation and degradation of Ang II and Ang-(1-7). Ang II acts at either the AT1 or the AT2 receptor to mediate opposing actions of vasoconstriction/vasodilation. While it is known that estrogen (E2) acts to down-regulate ACE and the AT1 receptors, its regulation of ACE2 and the AT2 receptor and the involvement of a specific estrogen receptor subtype are unknown. To investigate the role of estrogen receptor-á (ERá) in estrogen's regulation of ACE/ACE2 and AT1/AT2 mRNAs in lung and kidney, ovariectomized female mice lacking apolipoprotein E (ee) with the ERá (AAee) or without the ERá (ááee) were treated with 17-â estradiol (6 µg/day) or placebo for 3 months. ACE,ACE2 and AT1/AT2 receptor mRNAs were measured using reverse transcriptase, real-time polymerase chain reaction (RT/RT-PCR). In the kidney, 17-â estradiol showed 1.7 fold down-regulation of ACE mRNA in AAee mice, with 2.1-fold up-regulation of ACE mRNA in ááee mice. 17-â estradiol showed 1.5 and 1.8 fold down-regulation of ACE2 and AT1 receptor mRNA in AAee mice; this regulation was lost in ááee mice. 17-â estradiol showed marked (81-fold) up-regulation of the AT2 receptor mRNA in AAee mice. In the lung 17-â estradiol treatment had no effect on AT1 receptor mRNA in AAee mice, but resulted in a 1.5-fold decreased regulation of AT1 mRNA in ááee. There was no significant interaction of estrogen with ER in the lung for ACE, ACE2, and AT2 receptor genes. These studies reveal tissue specific regulation by 17-â estradiol of ACE/ACE2 and AT1/AT2 receptor genes with the ERá receptor primarily responsible for the regulation of kidney ACE2 , AT1 receptor, and AT2 receptor genes.

Key Words: Angiotensin, Gene expression, Hormones




This article has been cited by other articles:


Home page
Exp PhysiolHome page
M. K. Raizada and J. F. R. Paton
Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor
Exp Physiol, May 1, 2008; 93(5): 517 - 518.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the The Physiological Society.